Kevin B. Yankton - 10 Apr 2023 Form 4 Insider Report for Twist Bioscience Corp (TWST)

Role
Chief Accounting Officer
Signature
/s/ Alyssa Zhang, Attorney-in-Fact for Kevin B. Yankton
Issuer symbol
TWST
Transactions as of
10 Apr 2023
Net transactions value
-$1,040
Form type
4
Filing time
12 Apr 2023, 16:00:13 UTC
Previous filing
04 Apr 2023
Next filing
19 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TWST Common Stock Tax liability $1,040 -63 -0.68% $16.51 9,185 10 Apr 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e).
F2 Does not include 750 RSUs included in the Reporting Person's last Form 4 which were forfeited upon the reporting person's resignation as an officer, effective May 19, 2023.